QUIDE Drug Patent Profile
✉ Email this page to a colleague
When do Quide patents expire, and when can generic versions of Quide launch?
Quide is a drug marketed by Dow Pharm and is included in one NDA.
The generic ingredient in QUIDE is piperacetazine. There is one drug master file entry for this compound. Additional details are available on the piperacetazine profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for QUIDE?
- What are the global sales for QUIDE?
- What is Average Wholesale Price for QUIDE?
Summary for QUIDE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 43 |
| Patent Applications: | 799 |
| DailyMed Link: | QUIDE at DailyMed |
US Patents and Regulatory Information for QUIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dow Pharm | QUIDE | piperacetazine | TABLET;ORAL | 013615-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Dow Pharm | QUIDE | piperacetazine | TABLET;ORAL | 013615-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
